LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Ray Van Fossen New VP of Sales at Pinnacle Spine
People In The News

Ray Van Fossen New VP of Sales at Pinnacle Spine

December 30, 2014 1 min read Premium comments

Advertisement

Ray Van Fossen New VP of Sales at Pinnacle Spine
Ray Van Fossen

Ray Van Fossen, formerly with Medtronic, Inc. and Pioneer Medical Group, has joined Pinnacle Spine Group, LLC as the Vice President of Sales. According to Pinnacle Spine, Van Fossen brings more than 20 years of experience in spine and medical devices to the company’s team. He started as a sales representative for Medtronic; most recently Van Fossen held the position of VP of Sales for Pioneer Medical.

The December 5, 2014 corporate memo noted, “In his final year at Pioneer, he led the company to double-digit sales growth, helping make Pioneer a very attractive acquisition for another company within the spine industry.”

Paul J. Sendro noted in the memo, “You will find Ray to be a very forthright, pragmatic sales leader with whom I am sure you will enjoy working. We are excited and fortunate to have Ray joining our team.”

Van Fossen told OTW, “Pinnacle’s patented InFill technology provides a strong platform that we plan to complement with state of the art implant systems for our distribution partners. I expect that 2015 will be a break-out year at Pinnacle. Product line extensions, implant partnerships, acquisitions and an upgraded distribution network will result in record growth.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy